<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="cpr70011" xml:lang="en" article-type="letter"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Prolif</journal-id><journal-id journal-id-type="iso-abbrev">Cell Prolif</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1365-2184</journal-id><journal-id journal-id-type="publisher-id">CPR</journal-id><journal-title-group><journal-title>Cell Proliferation</journal-title></journal-title-group><issn pub-type="ppub">0960-7722</issn><issn pub-type="epub">1365-2184</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40000414</article-id><article-id pub-id-type="pmc">PMC12099214</article-id><article-id pub-id-type="doi">10.1111/cpr.70011</article-id><article-id pub-id-type="publisher-id">CPR70011</article-id><article-id pub-id-type="other">Cellprol-11338-25.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Letter to the Editor</subject></subj-group><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>Environmental Drivers of Malignant Clonal Selection in Precancerous Lesion Evolution</article-title></title-group><contrib-group><contrib id="cpr70011-cr-0001" contrib-type="author"><name><surname>Lai</surname><given-names>Yancheng</given-names></name><xref rid="cpr70011-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cpr70011-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="cpr70011-cr-0002" contrib-type="author" corresp="yes"><name><surname>Zhang</surname><given-names>Shaosen</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0010-1445</contrib-id><xref rid="cpr70011-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cpr70011-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>zhangss@cicams.ac.cn</email></address></contrib></contrib-group><aff id="cpr70011-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital</named-content>
<institution>Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="cpr70011-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Key Laboratory of Cancer Genomic Biology</named-content>
<institution>Chinese Academy of Medical Sciences and Peking Union Medical College</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Shaosen Zhang (<email>zhangss@cicams.ac.cn</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2025</year></pub-date><volume>58</volume><issue seq="120">5</issue><issue-id pub-id-type="doi">10.1111/cpr.v58.5</issue-id><elocation-id>e70011</elocation-id><history>
<date date-type="rev-recd"><day>05</day><month>2</month><year>2025</year></date>
<date date-type="received"><day>15</day><month>1</month><year>2025</year></date>
<date date-type="accepted"><day>13</day><month>2</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Cell Proliferation</italic> published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley &#x00026; Sons Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:CPR-58-e70011.pdf"/><abstract><title>ABSTRACT</title><p>Somatic mutations accumulation and subsequent malignant clonal selection are the processes that lead to cancer. The intricacy includes exposure to carcinogens as well as the ways in which these exposures interact with genetic, polygenic, or epigenetic predispositions. It is worthwhile to investigate how environmental factors influence the initial transformation of healthy cells into malignant ones, or their effects on promoting growth, invasion, immune evasion, inflammation and drug resistance of onset cancerous cells.</p></abstract><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Key Research and Development Program of China
</institution><institution-id institution-id-type="doi">10.13039/501100012166</institution-id></institution-wrap></funding-source><award-id>2023YFC3503200</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>National Natural Science Foundation of China
</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>82203156</award-id></award-group></funding-group><counts><fig-count count="2"/><table-count count="0"/><page-count count="5"/><word-count count="2900"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:23.05.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="cpr70011-ntgp-0001"><fn fn-type="funding" id="cpr70011-note-0001"><p>
<bold>Funding:</bold> This work was supported by National Key Research and Development Program of China (2023YFC3503200) and National Natural Science Foundation of China (82203156).</p></fn></fn-group></notes></front><body id="cpr70011-body-0001"><def-list list-content="abbreviations" id="cpr70011-dl-0001"><title>Abbreviations</title><def-item><term id="cpr70011-li-0001">CAFs</term><def id="cpr70011-li-0002"><p>cancer&#x02010;associated fibroblasts</p></def></def-item><def-item><term id="cpr70011-li-0003">CSCs</term><def id="cpr70011-li-0004"><p>cancer stem cells</p></def></def-item><def-item><term id="cpr70011-li-0005">ecDNA</term><def id="cpr70011-li-0006"><p>extrachromosomal DNA</p></def></def-item><def-item><term id="cpr70011-li-0007">ECM</term><def id="cpr70011-li-0008"><p>extracellular matrix</p></def></def-item><def-item><term id="cpr70011-li-0009">FAP</term><def id="cpr70011-li-0010"><p>familial adenomatous polyposis</p></def></def-item><def-item><term id="cpr70011-li-0011">HTAN</term><def id="cpr70011-li-0012"><p>Human Tumor Atlas Network</p></def></def-item><def-item><term id="cpr70011-li-0013">PME</term><def id="cpr70011-li-0014"><p>precancer microenvironment</p></def></def-item></def-list><sec id="cpr70011-sec-0001"><title>Main</title><p>Tumorigenesis is primarily driven by the accumulation of genetic and epigenetic alterations in oncogenes and tumour suppressor genes [<xref rid="cpr70011-bib-0001" ref-type="bibr">1</xref>]. It has been noted that abnormal clones caused by mutations may already be present during the embryonic or infantile period [<xref rid="cpr70011-bib-0002" ref-type="bibr">2</xref>], and these clones can be roughly divided into two main categories, the pro&#x02010;tumorigenic and the anti&#x02010;tumorigenic subtypes. Among the oncogenic clones, the division and expansion of stem cells lead to uncontrolled cell growth and malignant transformation, which is called cancer stem cells (CSCs) [<xref rid="cpr70011-bib-0003" ref-type="bibr">3</xref>]. CSCs have been found to possess a multitude of functional properties, including tumour initiation, self&#x02010;renewal, multipotency, plasticity, treatment resistance and the ability to maintain cancer stemness as a dynamic cellular state [<xref rid="cpr70011-bib-0004" ref-type="bibr">4</xref>]. Despite the accumulation of numerous oncogenic mutations in the normal tissues of healthy individuals as they age, tumour formation remains a rare occurrence [<xref rid="cpr70011-bib-0005" ref-type="bibr">5</xref>, <xref rid="cpr70011-bib-0006" ref-type="bibr">6</xref>]. Scientists have discovered that &#x02018;benign clones&#x02019; can be found in mutant polyclones to prevent precancerous clones from growing and progressing, but they are then overcome by tumour&#x02010;related clones. Finally, nearly all nearby clones that obstruct malignant cloning will eventually be eliminated, giving the local environment an oligoclonal or monoclonal composition [<xref rid="cpr70011-bib-0007" ref-type="bibr">7</xref>, <xref rid="cpr70011-bib-0008" ref-type="bibr">8</xref>]. This raises the question: what are the mechanisms that govern the dynamic competition between mutant clones, and how does this competition ultimately lead to premalignant transformation and early tumorigenesis?</p><p>To investigate these processes, researchers have initiated efforts to map the clonal evolution and competition throughout the normal&#x02010;precancer&#x02010;cancer continuum [<xref rid="cpr70011-bib-0009" ref-type="bibr">9</xref>, <xref rid="cpr70011-bib-0010" ref-type="bibr">10</xref>]. This involves the integration of spatial and temporal dimensions to illustrate the cellular and molecular evolution from normal tissue through the pre&#x02010;cancerous stage to cancer. Unravelling the complex ecosystem of diverse cell types involved in tumorigenesis necessitates more precise assessments of tissue morphology, cellular coordination and intercellular connections. Such insights are crucial for identifying the key drivers of tumorigenesis, their interconnections, and causality, as well as for pinpointing potential therapeutic targets and molecular markers for the early detection of precancerous lesions.</p><p>Driver mutations may confer advantages that enhance the adaptability and fitness of proliferating cells, leading to a dynamic ecosystem where the most fit clones proliferate, effectively transforming the tissue into a patchwork of mutant populations. For example, the competition between <italic toggle="yes">TP53</italic> and <italic toggle="yes">NOTCH1</italic> mutant clones in oesophageal precancer lesion is intricate and long&#x02010;lasting (Figure&#x000a0;<xref rid="cpr70011-fig-0001" ref-type="fig">1</xref>). We observe that the outcomes of this clonal selection appear to be linked to the influence of environmental selection, since immune surveillance and tumour&#x02010;associated antigen (TAA) signalling might mediate the removal of <italic toggle="yes">NOTCH1</italic> mutations from the prcancerous lesion, assisting the <italic toggle="yes">TP53</italic> mutant clone in becoming the dominant clone. The destabilisation of early clonal competitive balance, in our opinion, is mainly due to this environment&#x02010;induced clonal selection pressure. Colom et&#x000a0;al. also demonstrated that early and late lesions in the oesophageal epithelium are subject to distinct clonal selection pressures [<xref rid="cpr70011-bib-0011" ref-type="bibr">11</xref>]. Their further study focused on oesophageal cancer models subjected to mutagen exposure and natural aging processes. The authors highlight that cells in the clone centre exhibit genetic homogeneity and lack a selective advantage over adjacent cells. Mutant clone formation predominantly occurs at clone peripheries, where progenitor cells may encounter less fit neighbours. The biological basis underlying a cell's response to the genotype and fitness of its neighbouring cells potentially encompasses cytoskeletal and metabolic pathways, as well as cell&#x02013;cell communication mechanisms, such as NOTCH signalling. These findings underscore the critical role of the cellular microenvironment in clonal expansion and selection [<xref rid="cpr70011-bib-0012" ref-type="bibr">12</xref>].</p><fig position="float" fig-type="FIGURE" id="cpr70011-fig-0001"><label>FIGURE 1</label><caption><p>Clonal evolution events during precancerous progression through NOTCH1 and TP53 mutant clones as examples. Four distinct types of clonal events are commonly observed during the progression of precancerous lesions: Clonal Genesis, Clonal Equilibrium, Clonal Clearance and Clonal Proliferation. In the early stages, tumour&#x02010;suppressive mutant clones, exemplified by NOTCH1, establish dominance within the local niche and inhibit the expansion of malignant proliferative clones, such as those characterised by TP53 mutations. &#x02010;Along malignant transformation and tumor evolution, NOTCH1&#x02010;mutant clones undergo clonal clearance mediated by immune cells, which simultaneously release tumour&#x02010;associated antigen (TAA) signals. This process results in the clearance of TAA&#x02010;sharing clones, predominantly tumour&#x02010;suppressive clones like NOTCH1, while malignant clones such as those with TP53 mutations evade immune recognition and progressively occupy the ecological niche.</p></caption><graphic xlink:href="CPR-58-e70011-g002" position="anchor" id="jats-graphic-1"/></fig><p>Recent studies published in the Human Tumor Atlas Network (HTAN) collection of Nature offer novel insights into the evolution of precancerous clones [<xref rid="cpr70011-bib-0007" ref-type="bibr">7</xref>, <xref rid="cpr70011-bib-0013" ref-type="bibr">13</xref>, <xref rid="cpr70011-bib-0014" ref-type="bibr">14</xref>, <xref rid="cpr70011-bib-0015" ref-type="bibr">15</xref>]. The primary focus of most investigations has been on changes occurring within or between tumour clones, rather than on external pressures. Despite this, the role of environmental stress in clonal selection is gaining increasing attention. Environmental stress plays a dual role in clonal proliferation and selection. On one hand, it can facilitate cellular survival and acclimation to multifaceted microenvironments. On the other hand, adverse environmental conditions induce clonal competition, which enables malignant clones to emerge as the dominant population. A study has suggested that an immunosuppressive precancer microenvironment (PME) may contribute to monoclonal transformation. Cell&#x02010;to&#x02010;cell communication analyses based on ligand&#x02010;receptor interactions reveal that extracellular matrix (ECM) tissue and cell adhesion mechanisms may underlie the substantially elevated ligand&#x02010;receptor interactions between the epithelial subtypes of early polyclonal lesions compared to normal colon and advanced monoclonal lesions [<xref rid="cpr70011-bib-0007" ref-type="bibr">7</xref>]. An earlier study by Reeves et&#x000a0;al. also demonstrated that during the development of squamous carcinoma, adjacent wild&#x02010;type epithelial cells are recruited by the initial clones harbouring <italic toggle="yes">Hras</italic> mutations [<xref rid="cpr70011-bib-0016" ref-type="bibr">16</xref>]. Additionally, Esplin et&#x000a0;al. conducted a multi&#x02010;omics analysis of benign polyps, dysplastic polyps and normal mucosa in familial adenomatous polyposis (FAP) patients, revealing that the transition from precancerous lesions to cancer development entails a dynamic interplay of myriad molecular and cellular processes. These events encompass the immune system, cell division, hormonal signalling, extracellular matrix proteins and metabolic shifts, including alterations in lipid and amino acid metabolism [<xref rid="cpr70011-bib-0017" ref-type="bibr">17</xref>]. The results of the article also indicate that connections between the cell types involved in 63 proteomic and transcriptomic immunity pathways, which were enriched along the progression from normal to undesirable lesions, also revealed an extensive network of immune and neuronal cell types recruited in the Mucosa&#x02010;Dysplastic outcome. Additionally, the function of tissue structure and hormone&#x02010;mediated estrus cycles in breast duct clonal selection has recently come to light [<xref rid="cpr70011-bib-0018" ref-type="bibr">18</xref>]. Taken together, these findings appear to suggest a direct relationship between environmental stress and the emergence of tumour cloning.</p></sec><sec id="cpr70011-sec-0002"><title>The Future Prospect</title><p>Although the clonal evolutionary mechanisms underlying the transition from normal tissue to cancer are being gradually unravelled, it remains elusive how environmental pressures select polyclones in the early stages of tumorigenesis and ultimately drive their progression into malignant monoclones. Several &#x02018;benign clones&#x02019; reside in normal human tissues, and when exposed to stressors such as environmental stimulation, these clones evolve into one or a limited number of &#x02018;malignant clones&#x02019;. This process involves clonal evolution and competition, alterations in the composition and properties of the milieu, synergistic molecular pathways between epithelial cells and the microenvironment, and significant external environment&#x02010;driven events. We posit that this is a crucial question that has been overlooked by the majority of previous studies.</p><p>One intriguing hypothesis is that the robust cellular communication exhibited by early tumour polyclones may be a result of clones communicating more with each other in an attempt to find &#x02018;allies&#x02019;, an effect that is attenuated in the late stable monoclonal environment [<xref rid="cpr70011-bib-0007" ref-type="bibr">7</xref>]. During this process, the PME undergoes dynamic evolution, with the pattern of cellular interactions gradually shifting from benign to one that facilitates cancer progression. This transition can be attributed to various factors, including external photoelectric signals, hypoxia, alterations in pH and changes in the composition of the microbiome. Notably, the involvement of early immune response cells, such as neutrophils and antigen&#x02010;presenting cells, in clonal competition for precancer lesions may have more diverse functions than previously thought. While it has been shown that these factors can modify the microenvironment to create more aggressive and proliferative tumours, further investigation is necessary to elucidate the mechanisms by which clonal selection is linked to these factors.</p><p>Environmental stress plays a significant role in clonal selection, particularly during the transition from precancerous lesions to malignancy. Future research should investigate common characteristics of precancerous clonal selection across a broader spectrum of cancer lineages, as previous studies have focused on major tumour types such as breast, lung and colorectal cancer. Furthermore, to better understand the complex interactions and selection dynamics that occur within clones and between clones and microenvironments during the multistage evolution of normal&#x02010;precancer&#x02010;cancer, we need to establish a novel research paradigm that integrates spatiotemporal multiomics analysis, artificial intelligence&#x02010;driven computational strategies and advanced functional validation techniques.</p><p>Specifically, research relies on the accurate and efficient collection of human tissue samples through endoscopy and other screening techniques, as well as the establishment of a cohort that spans various stages of cancer development. In this context, the application of spatiotemporal multi&#x02010;omics analysis technology will overcome the limitations of traditional single&#x02010;cell sequencing and restore the fine spatial picture of cell interactions at single&#x02010;cell resolution. For instance, by employing methods such as SHARE&#x02010;seq&#x000a0;[<xref rid="cpr70011-bib-0019" ref-type="bibr">19</xref>] and CITE&#x02010;seq&#x000a0;[<xref rid="cpr70011-bib-0020" ref-type="bibr">20</xref>] in conjunction with multi&#x02010;stage sample collection, it is possible to achieve the integration of RNA, protein and chromatin information across multiple temporal dimensions. Moreover, the Perturb&#x02010;map technology [<xref rid="cpr70011-bib-0021" ref-type="bibr">21</xref>] enables the elucidation of functional genomics at single&#x02010;cell resolution in the spatial domain. These techniques are crucial for constructing a multidimensional map of cancer initiation and tumour evolution [<xref rid="cpr70011-bib-0014" ref-type="bibr">14</xref>].</p><p>Furthermore, artificial Intelligence techniques such as machine learning will be essential in integrating heterogeneous data, enhancing biological interpretation and predicting key driving events. For instance, deep learning algorithms like convolutional neural networks (CNNs) and recurrent neural networks (RNNs) can help analyse and interpret complex omics data, while natural language processing can aid in extracting insights from unstructured textual data such as scientific literature and clinical notes. The massive amounts of spatiotemporal omics data pose unprecedented challenges to data mining. Additional functional verification is required to elucidate the causative involvement of key molecular processes in carcinogenesis. Emerging research platforms, such as organoids and visual animal models, provide powerful tools for multi&#x02010;level validation from in&#x000a0;vitro to in&#x000a0;vivo.</p><p>Generally speaking, a crucial focus of future cancer research will be the integration of advanced spatiotemporal omics measurements, artificial intelligence analysis, and functional validation techniques to construct multidimensional evolutionary maps of various cancer stages, types and sites. This will necessitate the incorporation of environmental stress, precancerous lesion evolution, clonal selection and microenvironment shaping into a unified research framework. More importantly, we should not disregard or exclude the potential of any newly identified or previously recognised environmental factors or mechanisms in driving alterations in cellular behaviour that influence clonal selection. These factors encompass the recently elucidated mechanisms of microenvironmental mitochondrial transfer [<xref rid="cpr70011-bib-0022" ref-type="bibr">22</xref>], as well as mechanical stress [<xref rid="cpr70011-bib-0023" ref-type="bibr">23</xref>] and peritumoral neurotransmitters [<xref rid="cpr70011-bib-0024" ref-type="bibr">24</xref>] (Figure&#x000a0;<xref rid="cpr70011-fig-0002" ref-type="fig">2</xref>). Moreover, we should also focus on the stem&#x02010;like cell populations within these aberrant clones and investigate how environmental factors influence their behaviour and dynamics [<xref rid="cpr70011-bib-0025" ref-type="bibr">25</xref>, <xref rid="cpr70011-bib-0026" ref-type="bibr">26</xref>]. Overall, understanding and grasping the temporal and spatial nodes of macroscopic and microscopic environmental pressures in the polyclonal to monoclonal selection of normal&#x02010;precancerous cancers, along with the molecular mechanisms, will provide key insights to elucidate the general features of tumorigenesis. This will also establish the foundation for the development of personalised early prevention and treatment strategies.</p><fig position="float" fig-type="FIGURE" id="cpr70011-fig-0002"><label>FIGURE 2</label><caption><p>Interplay between environmental drivers and genetic or epigenetic predispositions on polyclonal to malignant clonal transition in precancerous lesion evolution. Somatic mutations accumulation is essential for cancer initiation and development, may arise as a result of spontaneous errors in normal DNA replication, during aging of quiescent cells, or by exposure to mutagens in the environment. Environmental pressures, encompassing both macroenvironmental and microenvironmental factors, play a crucial role in clonal selection and tumour progression across different temporal and spatial dimensions. Carcinogens, like stress, chronic disease, obesity, dietary factors and inflammation may also contribute to mutation burden indirectly. Oncogenic mutations may remain dormant in tissues of healthy individuals for long periods unless the tissue is repeatedly exposed to environmental carcinogens, causing positive selection of malignant cells carrying driver mutations. Known or suspected macro/microenvironmental promoting factors are shown as examples.</p></caption><graphic xlink:href="CPR-58-e70011-g001" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="cpr70011-sec-0003"><title>Author Contributions</title><p>S.Z. conceptualised and supervised the study. Y.L. drafted the manuscript and prepared the figures. S.Z. and Y.L. reviewed and prepared the final manuscript.</p></sec><sec sec-type="COI-statement" id="cpr70011-sec-0004"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec></body><back><sec sec-type="data-availability" id="cpr70011-sec-0006"><title>Data Availability Statement</title><p>Data sharing is not applicable to this article as no new data were created or analyzed in this study.</p></sec><ref-list content-type="cited-references" id="cpr70011-bibl-0001"><title>References</title><ref id="cpr70011-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cpr70011-cit-0001">
<string-name>
<given-names>S.</given-names>
<surname>Mustjoki</surname>
</string-name> and <string-name>
<given-names>N. S.</given-names>
<surname>Young</surname>
</string-name>, &#x0201c;<article-title>Somatic Mutations in &#x0201c;Benign&#x0201d; Disease</article-title>,&#x0201d; <source>New England Journal of Medicine</source>
<volume>384</volume> (<year>2021</year>): <fpage>2039</fpage>&#x02013;<lpage>2052</lpage>.<pub-id pub-id-type="pmid">34042390</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cpr70011-cit-0002">
<string-name>
<given-names>A.</given-names>
<surname>Jassim</surname>
</string-name>, <string-name>
<given-names>E. P.</given-names>
<surname>Rahrmann</surname>
</string-name>, <string-name>
<given-names>B. D.</given-names>
<surname>Simons</surname>
</string-name>, and <string-name>
<given-names>R. J.</given-names>
<surname>Gilbertson</surname>
</string-name>, &#x0201c;<article-title>Cancers Make Their Own Luck: Theories of Cancer Origins</article-title>,&#x0201d; <source>Nature Reviews Cancer</source>
<volume>23</volume> (<year>2023</year>): <fpage>710</fpage>&#x02013;<lpage>724</lpage>.<pub-id pub-id-type="pmid">37488363</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cpr70011-cit-0003">
<string-name>
<given-names>J.</given-names>
<surname>Hao</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Ma</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Wang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>General Requirements for Stem Cells</article-title>,&#x0201d; <source>Cell Proliferation</source>
<volume>53</volume> (<year>2020</year>): <elocation-id>e12926</elocation-id>.<pub-id pub-id-type="pmid">33146418</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cpr70011-cit-0004">
<string-name>
<given-names>J.&#x02010;J.</given-names>
<surname>Loh</surname>
</string-name> and <string-name>
<given-names>S.</given-names>
<surname>Ma</surname>
</string-name>, &#x0201c;<article-title>Hallmarks of Cancer Stemness</article-title>,&#x0201d; <source>Cell Stem Cell</source>
<volume>31</volume> (<year>2024</year>): <fpage>617</fpage>&#x02013;<lpage>639</lpage>.<pub-id pub-id-type="pmid">38701757</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cpr70011-cit-0005">
<string-name>
<given-names>R.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>di</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Li</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>A Body Map of Somatic Mutagenesis in Morphologically Normal Human Tissues</article-title>,&#x0201d; <source>Nature</source>
<volume>597</volume> (<year>2021</year>): <fpage>398</fpage>&#x02013;<lpage>403</lpage>.<pub-id pub-id-type="pmid">34433965</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cpr70011-cit-0006">
<string-name>
<given-names>K.</given-names>
<surname>Murai</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Dentro</surname>
</string-name>, <string-name>
<given-names>S. H.</given-names>
<surname>Ong</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>p53 Mutation in Normal Esophagus Promotes Multiple Stages of Carcinogenesis but Is Constrained by Clonal Competition</article-title>,&#x0201d; <source>Nature Communications</source>
<volume>13</volume> (<year>2022</year>): <fpage>6206</fpage>.</mixed-citation></ref><ref id="cpr70011-bib-0007"><label>7</label><mixed-citation publication-type="miscellaneous" id="cpr70011-cit-0007">
<string-name>
<given-names>Z.</given-names>
<surname>Lu</surname>
</string-name>, <article-title>&#x0201c;Polyclonal&#x02010;to&#x02010;Monoclonal Transition in Colorectal Precancerous Evolution.&#x0201d;</article-title>
</mixed-citation></ref><ref id="cpr70011-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cpr70011-cit-0008">
<string-name>
<given-names>S. M.</given-names>
<surname>Van Neerven</surname>
</string-name> and <string-name>
<given-names>L.</given-names>
<surname>Vermeulen</surname>
</string-name>, &#x0201c;<article-title>Cell Competition in Development, Homeostasis and Cancer</article-title>,&#x0201d; <source>Nature Reviews. Molecular Cell Biology</source>
<volume>24</volume> (<year>2023</year>): <fpage>221</fpage>&#x02013;<lpage>236</lpage>.<pub-id pub-id-type="pmid">36175766</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cpr70011-cit-0009">
<string-name>
<given-names>M. A.</given-names>
<surname>Taylor</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Kandyba</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Halliwill</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Stem&#x02010;Cell States Converge in Multistage Cutaneous Squamous Cell Carcinoma Development</article-title>,&#x0201d; <source>Science</source>
<volume>384</volume> (<year>2024</year>): <elocation-id>eadi7453</elocation-id>.<pub-id pub-id-type="pmid">38815020</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cpr70011-cit-0010">
<string-name>
<given-names>G.</given-names>
<surname>Han</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sinjab</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Rahal</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>An Atlas of Epithelial Cell States and Plasticity in Lung Adenocarcinoma</article-title>,&#x0201d; <source>Nature</source>
<volume>627</volume> (<year>2024</year>): <fpage>656</fpage>&#x02013;<lpage>663</lpage>.<pub-id pub-id-type="pmid">38418883</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cpr70011-cit-0011">
<string-name>
<given-names>B.</given-names>
<surname>Colom</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Herms</surname>
</string-name>, <string-name>
<given-names>M. W. J.</given-names>
<surname>Hall</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mutant Clones in Normal Epithelium Outcompete and Eliminate Emerging Tumours</article-title>,&#x0201d; <source>Nature</source>
<volume>598</volume> (<year>2021</year>): <fpage>510</fpage>&#x02013;<lpage>514</lpage>.<pub-id pub-id-type="pmid">34646013</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cpr70011-cit-0012">
<string-name>
<given-names>B.</given-names>
<surname>Colom</surname>
</string-name>, <string-name>
<given-names>M. P.</given-names>
<surname>Alcolea</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Piedrafita</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Spatial Competition Shapes the Dynamic Mutational Landscape of Normal Esophageal Epithelium</article-title>,&#x0201d; <source>Nature Genetics</source>
<volume>52</volume> (<year>2020</year>): <fpage>604</fpage>&#x02013;<lpage>614</lpage>.<pub-id pub-id-type="pmid">32424351</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="cpr70011-cit-0013">
<string-name>
<given-names>I. D.</given-names>
<surname>Sadien</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Adler</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Mehmed</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Polyclonality Overcomes Fitness Barriers in APC&#x02010;Driven Tumorigenesis</article-title>,&#x0201d; <source>Nature</source>
<volume>634</volume> (<year>2024</year>): <fpage>1196</fpage>&#x02013;<lpage>1203</lpage>.<pub-id pub-id-type="pmid">39478206</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="cpr70011-cit-0014">
<string-name>
<given-names>C.&#x02010;K.</given-names>
<surname>Mo</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Chen</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Tumour Evolution and Microenvironment Interactions in 2D and 3D Space</article-title>,&#x0201d; <source>Nature</source>
<volume>634</volume> (<year>2024</year>): <fpage>1178</fpage>&#x02013;<lpage>1186</lpage>.<pub-id pub-id-type="pmid">39478210</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="cpr70011-cit-0015">
<string-name>
<given-names>Y.</given-names>
<surname>Zhu</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>White</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Global Loss of Promoter&#x02013;Enhancer Connectivity and Rebalancing of Gene Expression During Early Colorectal Cancer Carcinogenesis</article-title>,&#x0201d; <source>Nature Cancer</source>
<volume>5</volume> (<year>2024</year>): <fpage>1697</fpage>&#x02013;<lpage>1712</lpage>, <pub-id pub-id-type="doi">10.1038/s43018-024-00823-z</pub-id>.<pub-id pub-id-type="pmid">39478119</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="cpr70011-cit-0016">
<string-name>
<given-names>M. Q.</given-names>
<surname>Reeves</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Kandyba</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Harris</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Del Rosario</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Balmain</surname>
</string-name>, &#x0201c;<article-title>Multicolour Lineage Tracing Reveals Clonal Dynamics of Squamous Carcinoma Evolution From Initiation to Metastasis</article-title>,&#x0201d; <source>Nature Cell Biology</source>
<volume>20</volume> (<year>2018</year>): <fpage>699</fpage>&#x02013;<lpage>709</lpage>.<pub-id pub-id-type="pmid">29802408</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="cpr70011-cit-0017">
<string-name>
<given-names>E. D.</given-names>
<surname>Esplin</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Hanson</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Wu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Multiomic Analysis of Familial Adenomatous Polyposis Reveals Molecular Pathways Associated With Early Tumorigenesis</article-title>,&#x0201d; <source>Nature Cancer</source>
<volume>5</volume> (<year>2024</year>): <fpage>1737</fpage>&#x02013;<lpage>1753</lpage>, <pub-id pub-id-type="doi">10.1038/s43018-024-00831-z</pub-id>.<pub-id pub-id-type="pmid">39478120</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="cpr70011-cit-0018">
<string-name>
<given-names>M.</given-names>
<surname>Ciwinska</surname>
</string-name>, <string-name>
<given-names>H. A.</given-names>
<surname>Messal</surname>
</string-name>, <string-name>
<given-names>H. R.</given-names>
<surname>Hristova</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mechanisms That Clear Mutations Drive Field Cancerization in Mammary Tissue</article-title>,&#x0201d; <source>Nature</source>
<volume>633</volume> (<year>2024</year>): <fpage>198</fpage>&#x02013;<lpage>206</lpage>.<pub-id pub-id-type="pmid">39232148</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="cpr70011-cit-0019">
<string-name>
<given-names>S.</given-names>
<surname>Ma</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>L. M.</given-names>
<surname>LaFave</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Chromatin Potential Identified by Shared Single&#x02010;Cell Profiling of RNA and Chromatin</article-title>,&#x0201d; <source>Cell</source>
<volume>183</volume> (<year>2020</year>): <fpage>1103</fpage>&#x02013;<lpage>1116.e20</lpage>.<pub-id pub-id-type="pmid">33098772</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="cpr70011-cit-0020">
<string-name>
<given-names>M.</given-names>
<surname>Stoeckius</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Hafemeister</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Stephenson</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Simultaneous Epitope and Transcriptome Measurement in Single Cells</article-title>,&#x0201d; <source>Nature Methods</source>
<volume>14</volume> (<year>2017</year>): <fpage>865</fpage>&#x02013;<lpage>868</lpage>.<pub-id pub-id-type="pmid">28759029</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="cpr70011-cit-0021">
<string-name>
<given-names>M.</given-names>
<surname>Dhainaut</surname>
</string-name>, <string-name>
<given-names>S. A.</given-names>
<surname>Rose</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Akturk</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Spatial CRISPR Genomics Identifies Regulators of the Tumor Microenvironment</article-title>,&#x0201d; <source>Cell</source>
<volume>185</volume> (<year>2022</year>): <fpage>1223</fpage>&#x02013;<lpage>1239.e20</lpage>.<pub-id pub-id-type="pmid">35290801</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="cpr70011-cit-0022">
<string-name>
<given-names>J. G.</given-names>
<surname>Baldwin</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Heuser&#x02010;Loy</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Saha</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Intercellular Nanotube&#x02010;Mediated Mitochondrial Transfer Enhances T Cell Metabolic Fitness and Antitumor Efficacy</article-title>,&#x0201d; <source>Cell</source>
<volume>187</volume> (<year>2024</year>): <fpage>6614</fpage>&#x02013;<lpage>6630.e21</lpage>, <pub-id pub-id-type="doi">10.1016/j.cell.2024.08.029</pub-id>.<pub-id pub-id-type="pmid">39276774</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="cpr70011-cit-0023">
<string-name>
<given-names>E.</given-names>
<surname>Cambria</surname>
</string-name>, <string-name>
<given-names>M. F.</given-names>
<surname>Coughlin</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Floryan</surname>
</string-name>, <string-name>
<given-names>G. S.</given-names>
<surname>Offeddu</surname>
</string-name>, <string-name>
<given-names>S. E.</given-names>
<surname>Shelton</surname>
</string-name>, and <string-name>
<given-names>R. D.</given-names>
<surname>Kamm</surname>
</string-name>, &#x0201c;<article-title>Linking Cell Mechanical Memory and Cancer Metastasis</article-title>,&#x0201d; <source>Nature Reviews Cancer</source>
<volume>24</volume> (<year>2024</year>): <fpage>216</fpage>&#x02013;<lpage>228</lpage>.<pub-id pub-id-type="pmid">38238471</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="cpr70011-cit-0024">
<string-name>
<given-names>Y.</given-names>
<surname>Hou</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Sun</surname>
</string-name>, <string-name>
<given-names>M. W.</given-names>
<surname>LaFleur</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Neuropeptide Signalling Orchestrates T Cell Differentiation</article-title>,&#x0201d; <source>Nature</source>
<volume>635</volume> (<year>2024</year>): <fpage>444</fpage>&#x02013;<lpage>452</lpage>, <pub-id pub-id-type="doi">10.1038/s41586-024-08049-w</pub-id>.<pub-id pub-id-type="pmid">39415015</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="cpr70011-cit-0025">
<string-name>
<given-names>M.</given-names>
<surname>H&#x000f6;rner</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Burkard</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Kelm</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Glial Cell Line Derived Neurotrophic Factor (<sc>gdnf</sc>) Induces Mucosal Healing via Intestinal Stem Cell Niche Activation</article-title>,&#x0201d; <source>Cell Proliferation</source>
<volume>58</volume> (<year>2024</year>): <elocation-id>e13758</elocation-id>, <pub-id pub-id-type="doi">10.1111/cpr.13758</pub-id>.<pub-id pub-id-type="pmid">39610047</pub-id>
</mixed-citation></ref><ref id="cpr70011-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="cpr70011-cit-0026">
<string-name>
<given-names>Z.</given-names>
<surname>Hao</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Lu</surname>
</string-name>, <string-name>
<given-names>S.&#x02010;Z.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>Y.&#x02010;T.</given-names>
<surname>Zhang</surname>
</string-name>, and <string-name>
<given-names>S.&#x02010;G.</given-names>
<surname>Xu</surname>
</string-name>, &#x0201c;<article-title>Stem Cell&#x02010;Derived Exosomes: A Promising Strategy for Fracture Healing</article-title>,&#x0201d; <source>Cell Proliferation</source>
<volume>50</volume> (<year>2017</year>): <elocation-id>e12359</elocation-id>.<pub-id pub-id-type="pmid">28741758</pub-id>
</mixed-citation></ref></ref-list></back></article>